Handa Pharmaceuticals (Taiwan) Insiders
| 6620 Stock | TWD 54.60 2.10 3.70% |
Handa Pharmaceuticals employs about 9 people. The company is managed by 9 executives with a total tenure of roughly 31 years, averaging almost 3.0 years of service per executive, having 1.0 employees per reported executive. Recap of Handa Pharmaceuticals' management performance can provide insight into the venture performance.
| Weili Lin Insider Independent Director |
| Meifang Zhang Insider Director |
Handa |
Handa Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (27.2) % which means that it has lost $27.2 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (41.47) %, meaning that it generated substantial loss on money invested by shareholders. Handa Pharmaceuticals' management efficiency ratios could be used to measure how well Handa Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Handa Pharmaceuticals Workforce Comparison
Handa Pharmaceuticals is number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is presently estimated at about 139. Handa Pharmaceuticals holds roughly 9.0 in number of employees claiming about 6% of equities under Drug Manufacturers—Specialty & Generic industry.
Handa Pharmaceuticals Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Handa Pharmaceuticals Price Series Summation is a cross summation of Handa Pharmaceuticals price series and its benchmark/peer.
Handa Pharmaceuticals Notable Stakeholders
A Handa Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Handa Pharmaceuticals often face trade-offs trying to please all of them. Handa Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Handa Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Guojun Song | Chief Technology Officer | Profile | |
| Weili Lin | Independent Director | Profile | |
| Meifang Zhang | Director | Profile | |
| Guiqing Wang | Independent Director | Profile | |
| Fangyu Liu | Chairman of the Board | Profile | |
| Xinyu Chen | Deputy General Manager-Finance | Profile | |
| Junliang Chen | General Manager, Director | Profile | |
| Xinfang Wu | Director | Profile | |
| Jin Wu | Independent Director | Profile |
About Handa Pharmaceuticals Management Performance
The success or failure of an entity such as Handa Pharmaceuticals often depends on how effective the management is. Handa Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Handa management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Handa management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Handa Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States and China. The company also develops modified release dosage forms, such as orally disintegrating tablets, modified release orally disintegrating tablets, modified release suspension systems, and ophthalmic modified release systems. HANDA PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange.
Please note, the imprecision that can be found in Handa Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Handa Pharmaceuticals. Check Handa Pharmaceuticals' Beneish M Score to see the likelihood of Handa Pharmaceuticals' management manipulating its earnings.
Handa Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Handa Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Handa Pharmaceuticals within its industry.Handa Pharmaceuticals Manpower Efficiency
Return on Handa Pharmaceuticals Manpower
| Revenue Per Employee | 3.2M | |
| Revenue Per Executive | 3.2M | |
| Net Loss Per Employee | 31.3M | |
| Net Loss Per Executive | 31.3M |
Additional Tools for Handa Stock Analysis
When running Handa Pharmaceuticals' price analysis, check to measure Handa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Handa Pharmaceuticals is operating at the current time. Most of Handa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Handa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Handa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Handa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.